336 related articles for article (PubMed ID: 29411216)
1. Pharmacological treatments for heart failure with preserved ejection fraction-a systematic review and indirect comparison.
Bonsu KO; Arunmanakul P; Chaiyakunapruk N
Heart Fail Rev; 2018 Mar; 23(2):147-156. PubMed ID: 29411216
[TBL] [Abstract][Full Text] [Related]
2. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
[TBL] [Abstract][Full Text] [Related]
3. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
[TBL] [Abstract][Full Text] [Related]
4. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
Turgeon RD; Kolber MR; Loewen P; Ellis U; McCormack JP
PLoS One; 2019; 14(2):e0212907. PubMed ID: 30817783
[TBL] [Abstract][Full Text] [Related]
5. Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis.
Xiang B; Zhang R; Wu X; Zhou X
JAMA Netw Open; 2022 Sep; 5(9):e2231963. PubMed ID: 36125813
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).
Capuano A; Scavone C; Vitale C; Sportiello L; Rossi F; Rosano GM; Coats AJ
Int J Cardiol; 2015 Dec; 200():15-9. PubMed ID: 26404747
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis.
Berbenetz NM; Mrkobrada M
BMC Cardiovasc Disord; 2016 Dec; 16(1):246. PubMed ID: 27905877
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.
Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK
Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582
[TBL] [Abstract][Full Text] [Related]
9. Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
Zheng SL; Chan FT; Nabeebaccus AA; Shah AM; McDonagh T; Okonko DO; Ayis S
Heart; 2018 Mar; 104(5):407-415. PubMed ID: 28780577
[TBL] [Abstract][Full Text] [Related]
10. Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
Kapelios CJ; Murrow JR; Nührenberg TG; Montoro Lopez MN
Heart Fail Rev; 2019 May; 24(3):367-377. PubMed ID: 30618017
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: a systematic review and network meta-analysis of 32 randomized trials.
Pamporis K; Karakasis P; Sagris M; Zarifis I; Bougioukas KI; Pagkalidou E; Milaras N; Samaras A; Theofilis P; Fragakis N; Tousoulis D; Xanthos T; Giannakoulas G
Curr Probl Cardiol; 2024 Jul; 49(7):102615. PubMed ID: 38692445
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
Khan MS; Fonarow GC; Khan H; Greene SJ; Anker SD; Gheorghiade M; Butler J
ESC Heart Fail; 2017 Nov; 4(4):402-408. PubMed ID: 28869332
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Network Meta-Analysis.
Sreenivasan J; Malik A; Khan MS; Lloji A; Hooda U; Aronow WS; Lanier GM; Pan S; Greene SJ; Murad MH; Michos ED; Cooper HA; Gass A; Gupta R; Desai NR; Mentz RJ; Frishman WH; Panza JA
Cardiol Rev; 2024 Mar-Apr 01; 32(2):114-123. PubMed ID: 36576372
[TBL] [Abstract][Full Text] [Related]
14. Effect of renin-angiotensin system inhibitors on mortality in heart failure with preserved ejection fraction: a meta-analysis of observational cohort and randomized controlled studies.
Fukuta H; Goto T; Wakami K; Ohte N
Heart Fail Rev; 2017 Nov; 22(6):775-782. PubMed ID: 28702858
[TBL] [Abstract][Full Text] [Related]
15. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews.
Al-Gobari M; Al-Aqeel S; Gueyffier F; Burnand B
BMJ Open; 2018 Jul; 8(7):e021108. PubMed ID: 30056380
[TBL] [Abstract][Full Text] [Related]
17. Effects of renin-angiotensin-aldosterone system inhibitors on mortality, hospitalization, and diastolic function in patients with HFpEF. A meta-analysis of 13 randomized controlled trials.
Zhang Q; Chen Y; Liu Q; Shan Q
Herz; 2016 Feb; 41(1):76-86. PubMed ID: 26272273
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials.
Xiang Y; Shi W; Li Z; Yang Y; Wang SY; Xiang R; Feng P; Wen L; Huang W
Medicine (Baltimore); 2019 Mar; 98(13):e14967. PubMed ID: 30921200
[TBL] [Abstract][Full Text] [Related]
19. Medical Therapies for Heart Failure With Preserved Ejection Fraction.
Kjeldsen SE; von Lueder TG; Smiseth OA; Wachtell K; Mistry N; Westheim AS; Hopper I; Julius S; Pitt B; Reid CM; Devereux RB; Zannad F
Hypertension; 2020 Jan; 75(1):23-32. PubMed ID: 31786973
[TBL] [Abstract][Full Text] [Related]
20. Treatment with renin-angiotensin system inhibitors and prognosis of heart failure with preserved ejection fraction: A propensity-matched study in the community.
Egido JJ; Gomez R; Romero SP; Andrey JL; Ramirez D; Rodriguez A; Pedrosa MJ; Gomez F
Int J Clin Pract; 2019 Jun; 73(6):e13317. PubMed ID: 30694579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
